UBR5 and neoplasm: Tumor grade (G4 vs. G1, p = 5.6E-03; G3 vs. G2, p = 5.6E−04; G3 vs. G1, p = 1.7E−06; G2 vs. G1, p = 4.7E−02), age (41–60 years vs. 61–80 years, p = 1.8E-02), weight (normal weight vs. obese, p = 9.1E-03), and TP53 mutation status (mutant vs. non-mutant, p = 9.1E-03) were strongly correlated with UBR5 expression (Figures 2C–J).